Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 15;16(12):7262-7277.
doi: 10.62347/NJMJ7853. eCollection 2024.

The therapeutic potential of Honeysuckle in cardiovascular disease: an anti-inflammatory intervention strategy

Yue Zhao  1 , Jiale Zhang  2   3 , Fei Lu  4 , Weiming Xu  2   3 , Qingxiao Ma  5 , Jingqing Hu  1   2   6
Affiliations
Review

The therapeutic potential of Honeysuckle in cardiovascular disease: an anti-inflammatory intervention strategy

Yue Zhao et al. Am J Transl Res. .

Abstract

Honeysuckle is a conventional Chinese medicine with several therapeutic applications. With the advancement of modern scientific technologies, Honeysuckle's pharmacological effects and medicinal properties have been investigated more thoroughly. Studies demonstrate that the bioactive compounds in Honeysuckle possess anti-inflammatory effects via several mechanisms, protecting the cardiovascular system. This article provides a reference for the clinical use of Honeysuckle by reviewing research on the therapeutic impact of Honeysuckle and its active constituents on cardiovascular diseases, such as coronary atherosclerotic heart disease (CHD), myocardial ischemia-reperfusion (MI/R), acute myocardial infarction (AMI), hypertension, arrhythmia, and heart failure, through the inhibition of inflammatory responses.

Keywords: Honeysuckle; anti-inflammatory; cardiovascular disease; review.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
Chlorogenic acid (A), Caffeic acid (B), Luteolin (C), Quercetin (D).
See this image and copyright information in PMC

References

    1. World Health Organization. (2024) Cardiovascular disease. Available at: https://www.who.int/health-topics/cardiovascular-diseases/ (Accessed: 1 July, 2024)
    1. Ridker PM, Koenig W, Kastelein JJ, Mach F, Luscher TF. Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention? Eur Heart J. 2018;39:4109–4111. - PubMed
    1. Ridker PM. A test in context: high-sensitivity C-reactive protein. J Am Coll Cardiol. 2016;67:712–723. - PubMed
    1. Zhang RM, Mcnerney KP, Riek AE, Bernal-Mizrachi C. Immunity and hypertension. Acta Physiol (Oxf) 2021;231:e13487. - PMC - PubMed
    1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet. 1997;349:1498–1504. - PubMed

LinkOut - more resources